Speaker illustration

Mrs Aristi Boulmpou

Hippokration General Hospital of Thessloniki, Thessaloniki (Greece)

Member of:

European Society of Cardiology

I was born in Nea Moudania, Chalkidiki, Greece, in 1993. I studied Medicine in Aristotle University of Thessaloniki and I received my M.D. degree in 2017. In 2019, I completed (with Excellence Scholarship) my M.Sc in Healthcare Management (University of Macedonia, Thessaloniki, Greece). I worked as a Resident in Internal Medicine (2017-2020) in Agios Pavlos General Hospital (Thessaloniki, Greece). I currently serve as a Resident in Cardiology in the Third Department of Cardiology (Ippokratio General Hospital, Thessaloniki, Greece). I am a PhD candidate in Aristotle University of Thessaloniki, focusing on the role of cardiopulmonary exercise testing in atrial fibrillation prognosis. I am a Professional Member of the European Society of Cardiology. I currently work on a series of research projects and I speak fluently 4 languages (Greek, English, German, French), I am a pianist and I enjoy studying.

Impact of antidiabetic treatment with dipeptidyl peptidase-4 inhibitors on the risk of cardiac arrhythmias among patients with type 2 diabetes mellitus

Event: ESC Congress 2021 - The Digital Experience

Topic: Antidiabetic Pharmacotherapy

Session: Pharmacology and pharmacotherapy e-posters

Thumbnail

Sodium-glucose co-transporter-2 inhibitors and the risk of major arrhythmias: a meta-analysis of the cardiovascular and renal outcome trials

Event: ESC Congress 2021 - The Digital Experience

Topic: Antidiabetic Pharmacotherapy

Session: Congress committee e-posters choice in pharmacology and pharmacotherapy

Thumbnail

Meta-analysis of cardiovascular outcome trials assessing the impact of glucagon-like peptide-1 receptor agonists on major cardiac arrhythmias

Event: ESC Congress 2021 - The Digital Experience

Topic: Antidiabetic Pharmacotherapy

Session: Congress committee e-posters choice in pharmacology and pharmacotherapy

Thumbnail

Risk of death with sodium-glucose co-transporter-2 inhibitors across the hallmark cardiovascular and renal outcome trials: an updated meta-analysis

Event: ESC Congress 2021 - The Digital Experience

Topic: Antidiabetic Pharmacotherapy

Session: Pharmacology and pharmacotherapy e-posters

Thumbnail

The effect of glucagon-like peptide-1 receptor agonists on 24-hour ambulatory blood pressure: a meta-analysis

Event: ESC Congress 2021 - The Digital Experience

Topic: Antidiabetic Pharmacotherapy

Session: Pharmacology and pharmacotherapy e-posters

Thumbnail

Effects of different exercise training programs versus usual care on peak oxygen uptake of patients with HFpEF

Event: Heart Failure 2021 Online Congress

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: ePoster session

Thumbnail

Impact of resistance and high intensity interval training on peak oxygen uptake of patients with HFpEF compared to aerobic exercise

Event: Heart Failure 2021 Online Congress

Topic: Rehabilitation

Session: ePoster session

Thumbnail

Chronic kidney disease and diabetes status do not affect efficacy of SGLT-2 inhibitors in patients with heart failure with reduced ejection fraction

Event: Heart Failure 2021 Online Congress

Topic: Antidiabetic Pharmacotherapy

Session: ePoster session

Thumbnail

This platform is supported by

logo Novo Nordisk